Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment

In a minority of depressed patients, treatment with an antidepressant drug appears to initiate intense suicidal thoughts and actions. We describe this phenomenon in a 52-year-old woman treated with escitalopram. She did not experience this when treated with six other antidepressants, which were not...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Farooq, Bernadt, Morris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195160/
https://www.ncbi.nlm.nih.gov/pubmed/22021958
http://dx.doi.org/10.4103/0253-7176.85400
_version_ 1782214080411467776
author Khan, Farooq
Bernadt, Morris
author_facet Khan, Farooq
Bernadt, Morris
author_sort Khan, Farooq
collection PubMed
description In a minority of depressed patients, treatment with an antidepressant drug appears to initiate intense suicidal thoughts and actions. We describe this phenomenon in a 52-year-old woman treated with escitalopram. She did not experience this when treated with six other antidepressants, which were not Selective Serotonin Reuptake Inhibitors. Clinicians need to warn patients and their relatives of the risk that intense suicidal thoughts may develop after an antidepressant drug is started and encourage them to seek help immediately should this occur.
format Online
Article
Text
id pubmed-3195160
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31951602011-10-21 Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment Khan, Farooq Bernadt, Morris Indian J Psychol Med Case Report In a minority of depressed patients, treatment with an antidepressant drug appears to initiate intense suicidal thoughts and actions. We describe this phenomenon in a 52-year-old woman treated with escitalopram. She did not experience this when treated with six other antidepressants, which were not Selective Serotonin Reuptake Inhibitors. Clinicians need to warn patients and their relatives of the risk that intense suicidal thoughts may develop after an antidepressant drug is started and encourage them to seek help immediately should this occur. Medknow Publications 2011 /pmc/articles/PMC3195160/ /pubmed/22021958 http://dx.doi.org/10.4103/0253-7176.85400 Text en Copyright: © Indian Journal of Psychological Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Khan, Farooq
Bernadt, Morris
Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment
title Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment
title_full Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment
title_fullStr Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment
title_full_unstemmed Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment
title_short Intense Suicidal Thoughts and Self-Harm Following Escitalopram Treatment
title_sort intense suicidal thoughts and self-harm following escitalopram treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195160/
https://www.ncbi.nlm.nih.gov/pubmed/22021958
http://dx.doi.org/10.4103/0253-7176.85400
work_keys_str_mv AT khanfarooq intensesuicidalthoughtsandselfharmfollowingescitalopramtreatment
AT bernadtmorris intensesuicidalthoughtsandselfharmfollowingescitalopramtreatment

Ejemplares similares